Naomi Detablan
Foot & Ankle Surgery · Baltimore, MDNPI 1679986970
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Evolution Surgical, Inc at 57.4% of the total. Reporting peaked in 2019 at $4,309 and has fallen 77.9% since, to $954 in 2023.
Across 41 payments — averaging $162.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Evolution Surgical, Inc$4K
- Stryker$2K
- Supreme Orthopedic Systems, LLC$491
- Arthrex$462
- Osiris Therapeutics Inc.$120
- Derma Sciences, Inc.$62
- plus $178 from 6 others
What the payments were for
- Travel & lodging$1,68525%
- Food & beverage$1,31320%
- Education$3,65855%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Evolution Surgical, Inc | 4 | $3,819 |
| Stryker(2 entities) | 22 | $1,523 |
| Supreme Orthopedic Systems, LLC | 2 | $491 |
| Arthrex | 4 | $462 |
| Osiris Therapeutics Inc. | 1 | $120 |
| Derma Sciences, Inc. | 2 | $62 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $50 |
| Smith+Nephew | 1 | $45 |
| Accufix Surgical Inc. | 1 | $28 |
| Heron Therapeutics, Inc. | 1 | $22 |
| Aroa Biosurgery Incorporated | 1 | $21 |
| Orthofix Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,656 in reported general payments places this provider in the 70th percentile of 182 foot & ankle surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 105 | $2,704 |
| Terbinafine Hcl | 26 | $746 |
| Ketoconazole | 25 | $550 |
| Diclofenac Sodium | 11 | $382 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $211 |
| Doxycycline Monohydrate | 17 | $171 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Baltimore
- Lew SchonBaltimore$752K
- Stuart MillerBaltimore$583K
- Patrick MaloneyBaltimore$262K
- Gregory GuytonBaltimore$216K
- Clifford JengBaltimore$74K
- Kyung SeoBaltimore$23K
- Richard SmithBaltimore$18K
- Jacob WisbeckBaltimore$17K
- Stephen JacobsenBaltimore$17K
- Brady WilliamsBaltimore$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.